Black Diamond Therapeutics, Inc. (BDTX) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Black Diamond Therapeutics, Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BDTX
Black Diamond Therapeutics, Inc.
$1.88HealthcareDelayed quote: Oct 6, 2026, 1:03 PM EDT
LENZ
LENZ Therapeutics, Inc.
$3.73HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — BDTX vs LENZ
growth of $100 · dividends reinvested · last 5yBDTX -84.9% (-31.5%/yr)LENZ -91.4% (-38.7%/yr)BDTX compounded faster over this window
BDTX LENZ
BDTX vs LENZ: by the numbers
- •LENZ is the larger company ($117M vs $107M market cap).
- •BDTX is profitable (31.95% net margin) while LENZ runs a net loss (-586.74%).
Metrics side by side
Valuation
| Metric | BDTX | LENZ |
|---|---|---|
| P/S ratio | N/A | 5.44 |
| P/B ratio | 1.12 | 0.53 |
Profitability
| Metric | BDTX | LENZ |
|---|---|---|
| Gross margin | 99.54% | 90.14% |
| Operating margin | 28.39% | -477.46% |
| Net margin | 31.95% | -586.74% |
| ROE | -44.29% | -57.47% |
| ROIC | -47.54% | -61.84% |
Growth (annualized)
| Metric | BDTX | LENZ |
|---|---|---|
| Total return CAGR (5Y) | -24.47% | -35.49% |
Frequently asked
- Is BDTX or LENZ more profitable?
- BDTX runs the higher net margin — BDTX at 31.95% versus LENZ at -586.74%.
- How have BDTX and LENZ total returns compared?
- Over the past 5 years, BDTX delivered -24.47% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.